Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126466532 | 12646653 | 2 | F | 20160818 | 20160812 | 20160831 | EXP | JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-121637 | RANBAXY | SATO Y, DODEN K, NISHIDA Y, SHIMIZU S, TANAKA N, YAGI D, ET AL. BEVACIZUMAB THERAPY FOR A COLORECTAL CANCER PATIENT OR HEMODIALYSIS WITH HEPATIC METASTASIS. GAN-TO-KAGAKU-RYOHO. 2013;40 (5):647-450 | 67.00 | YR | M | Y | 0.00000 | 20160831 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126466532 | 12646653 | 1 | PS | OXALIPLATIN. | OXALIPLATIN | 1 | Unknown | 2 CYCLES | U | 202922 | |||||||||
| 126466532 | 12646653 | 2 | C | Bevacizumab | BEVACIZUMAB | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126466532 | 12646653 | 3 | C | Folinic acid | LEUCOVORIN | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126466532 | 12646653 | 4 | C | FLUOROURACIL. | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | UNK | U | U | 0 | ||||||||
| 126466532 | 12646653 | 5 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126466532 | 12646653 | 1 | Metastases to liver |
| 126466532 | 12646653 | 2 | Metastases to liver |
| 126466532 | 12646653 | 3 | Metastases to liver |
| 126466532 | 12646653 | 4 | Metastases to liver |
| 126466532 | 12646653 | 5 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126466532 | 12646653 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126466532 | 12646653 | Bone marrow failure | |
| 126466532 | 12646653 | Decreased appetite | |
| 126466532 | 12646653 | Neutrophil count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126466532 | 12646653 | 1 | 201103 | 0 | ||
| 126466532 | 12646653 | 2 | 201103 | 0 | ||
| 126466532 | 12646653 | 3 | 201103 | 0 | ||
| 126466532 | 12646653 | 4 | 201103 | 0 |